S-1: iCoreConnect Files for Resale of Up to 1,299,672 Common Shares

iCoreConnect has filed a registration statement for the resale of up to 1,299,672 shares of its common stock by selling stockholders, including shares issuable upon conversion of convertible notes and shares related to an equity purchase agreement.

Summary

• iCoreConnect has filed a registration statement for the resale of up to 1,299,672 shares of its common stock.
• The shares are being offered by selling stockholders, including Crom Structured Opportunities Fund I, LP, Crom Cortana Fund LLC, and Jefferson Street Capital LLC.
• The offering includes up to 285,000 shares related to an equity purchase agreement with CROM, up to 500,000 shares issuable upon conversion of February Convertible Notes, up to 500,000 shares issuable upon conversion of December Convertible Notes, and 14,672 commitment shares.
• iCoreConnect will not receive any proceeds from the sale of these shares.
• The company is an emerging growth company and a smaller reporting company, which allows for reduced public company reporting requirements.
• The company has entered into an Equity Purchase Agreement with CROM, committing CROM to purchase up to $20.0 million of common stock at the company's direction.
• The company has also entered into securities purchase agreements for convertible notes, with potential for conversion into common stock at varying prices and subject to certain limitations.
• The company has also entered into securities purchase agreements for convertible notes, with potential for conversion into common stock at varying prices and subject to certain limitations.
• The company has also entered into securities purchase agreements for convertible notes, with potential for conversion into common stock at varying prices and subject to certain limitations.

Sentiment

Score: 5

Explanation: The document is primarily factual and descriptive, outlining the terms of a securities offering. While the company gains access to potential capital, the offering also presents risks of dilution and downward pressure on the stock price. The sentiment is neutral.

Positives

• The company has access to a $20.0 million commitment from CROM through an equity purchase agreement.
• The company has obtained shareholder approval for the issuance of common stock underlying the notes, complying with Nasdaq requirements.

Negatives

• The company will not receive any proceeds from the sale of shares by the selling stockholders.
• The sale of shares by selling stockholders may put downward pressure on the stock price.
• The company has a working capital deficit of $11,670,852 as of September 30, 2024.
• The company has an accumulated deficit of $138,213,468 as of September 30, 2024.

Risks

• The market price of the common stock may be volatile.
• The company may be delisted from The Nasdaq Capital Market which could have a material adverse effect on our financial condition and could make it more difficult for you to sell your shares.
• The company is an emerging growth company and it cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors, which may make it more difficult to compare our performance with other public companies.
• The sale and issuance of our common stock to CROM will cause dilution to our existing stockholders, and the sale of the shares of our common stock acquired by CROM, or the perception that such sales may occur, could cause the price of our common stock to fall.

Future Outlook

The company expects that any proceeds received from sales to CROM will be used for working capital and general corporate purposes.

Industry Context

This announcement is typical for companies seeking to raise capital and provide liquidity for early investors. The use of convertible notes and equity lines of credit is common in the current market environment, particularly for smaller reporting companies.

Comparison to Industry Standards

• Comparable companies in the SaaS space often utilize similar financing strategies, including convertible notes and equity lines of credit, to fund growth and operations.
• The specific terms of the convertible notes, such as the conversion price and interest rate, are generally in line with industry standards for companies of similar size and risk profile.
• The equity purchase agreement with CROM is similar to arrangements used by other companies to provide flexible access to capital, with the timing and amount of sales dependent on market conditions and the company's needs.

Stakeholder Impact

• Existing shareholders may experience dilution due to the potential issuance of new shares.
• The offering may provide the company with additional capital to fund its operations and growth.
• The market price of the common stock may be affected by the offering.

Next Steps

• The company will file a registration statement with the SEC for the resale of the common stock.
• The company may sell shares of its common stock to CROM under the Equity Purchase Agreement.
• The company may need to seek stockholder approval to issue shares of common stock in excess of 19.99% of the outstanding shares.

Key Dates

Keywords

common stock, convertible notes, equity purchase agreement, resale, registration statement, selling stockholders, CROM, iCoreConnect, shares, notes